CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net earnings	$ 161	$ 471	$ 719
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	236	224	211
Stock-based compensation	73	52	50
Deferred income taxes	(149)	5	(32)
Goodwill, trademark and other asset impairments	445	0	329
Settlement of interest rate derivative contracts	0	114	0
Other	38	19	10
Changes in:
Receivables, net	(13)	(84)	82
Inventories, net	58	(18)	(282)
Prepaid expenses and other current assets	(1)	16	(30)
Accounts payable and accrued liabilities	157	(47)	311
Operating lease right-of-use assets and liabilities, net	1	(1)	(2)
Income taxes payable/prepaid	152	35	(90)
Net cash provided by operations	1,158	786	1,276
Investing activities:
Capital expenditures	(228)	(251)	(331)
Businesses acquired, net of cash acquired	0	0	(85)
Other	5	22	(36)
Net cash used for investing activities	(223)	(229)	(452)
Financing activities:
Notes and loans payable, net	(188)	237	0
Long-term debt repayments	0	(1,405)	0
Long-term debt borrowings, net of issuance costs paid	0	1,085	0
Treasury stock purchased	0	(25)	(905)
Cash dividends paid to Clorox stockholders	(583)	(571)	(558)
Cash dividends paid to noncontrolling interests	(15)	(15)	(31)
Issuance of common stock for employee stock plans and other	33	5	103
Net cash used for financing activities	(753)	(689)	(1,391)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(6)	12
Net increase (decrease) in cash, cash equivalents and restricted cash	182	(138)	(555)
Cash, cash equivalents and restricted cash:
Beginning of year	186	324	879
End of year	368	186	324
Supplemental cash flow information:
Interest paid	99	89	89
Income taxes paid, net of refunds	73	100	303
Noncash financing activities:
Cash dividends declared and accrued, but not paid	$ 16	$ 14	$ 156